Globalink Investment Inc. (GLLI): History, Ownership, Mission, How It Works & Makes Money

Globalink Investment Inc. (GLLI) just completed a massive reverse merger in late 2025-but what does a $1.6 billion deal size mean for a company with a negative TTM Cash from Operations of -$2.17 million?

As a Special Purpose Acquisition Company (SPAC), GLLI's entire mission was to find a target in the high-growth medical technology or green energy sectors, a search that culminated in the October 2025 acquisition by ALPS Global Holding Berhad.

We'll defintely break down the history, the unusual 339.94% Total Liabilities/Total Assets ratio, and the new business model to help you understand if this post-merger entity is a strategic opportunity or a classic SPAC risk.

Globalink Investment Inc. (GLLI) History

You're looking for the real story behind Globalink Investment Inc. (GLLI), and the direct takeaway is this: it was a classic Special Purpose Acquisition Company (SPAC) that successfully executed its primary function-merging with a private operating company-just before its final deadline in late 2025. This entire history is a short, sharp sprint from a blank check to a biotech holding company.

Given Company's Founding Timeline

Globalink Investment Inc. was formed to raise capital through an Initial Public Offering (IPO) and then acquire a target company, a process known as a de-SPAC transaction. It was a vehicle, not an operating business, which is why its financial history is dominated by trust account balances and merger expenses.

Year established

The company was founded in 2021.

Original location

Globalink Investment Inc. was incorporated in Newark, Delaware, and maintained a corporate office in New York, NY, at 1180 Avenue of the Americas for its IPO.

Founding team members

The company was led by CEO Say Leong Lim.

Initial capital/funding

The initial capital raised through the IPO, which was priced on December 6, 2021, was approximately $100 million, based on 10 million units at $10.00 each. The total IPO proceeds were reported at $115.00 million.

Given Company's Evolution Milestones

The history of a SPAC is a countdown to a merger, and GLLI's timeline shows a pivot in focus and a persistent effort to close a deal, marked by numerous deadline extensions.

Given Company's Transformative Moments

The most transformative period for Globalink Investment Inc. was the back-to-back sequence of merger approvals and the final closing in late 2025. Honestly, the entire purpose of a SPAC is this one moment.

The shift in target focus was a major course correction. Initially, the team planned to acquire a company in technology, specifically e-commerce and payments. By 2024, the focus had shifted to medical technology and green energy, which led to the deal with Alps Life Sciences Inc.

The most recent and critical actions in 2025 were all about execution and survival:

• Securing the Merger: Stockholders approved the merger on October 7, 2025, with 3,445,007 shares voting in favor.
• Managing Redemptions: During the merger process, 59,966 shares were redeemed for cash, leaving only 12,635 public shares outstanding, which is a common, though dramatic, feature of SPAC mergers.
• Final Extension: The company extended its deadline for the business combination to November 9, 2025, with a deposit of $10,890.15 into the trust account on October 4, 2025. This shows the defintely tight timeline they were working under.

The financial picture leading up to the merger showed the typical costs of a SPAC waiting for a deal, with a trailing twelve-month (TTM) Net Income of -$2.02 million as of August 2025, and Cash from Operations (TTM) at -$2.17 million as of October 2025. This is the cost of doing business as a blank check company. You can dig deeper into the post-merger entity's health here: Breaking Down Globalink Investment Inc. (GLLI) Financial Health: Key Insights for Investors

Globalink Investment Inc. (GLLI) Ownership Structure

The ownership structure of Globalink Investment Inc. (GLLI) is typical of a Special Purpose Acquisition Company (SPAC), characterized by a significant stake held by institutional investors and a small public float, especially following recent share redemptions related to its impending business combination.

The company is currently controlled by a mix of institutional funds and its sponsor, with the public float shrinking dramatically as the merger with Alps Life Sciences Inc. approaches, which was approved by stockholders on October 7, 2025. This structure means strategic decisions are heavily influenced by the major institutional shareholders and the management team driving the deal.

Globalink Investment Inc.'s Current Status

Globalink Investment Inc. is a publicly traded blank check company, or SPAC, trading on the OTC Pink market under the ticker GLLI, having been delisted from NASDAQ. It was formed to effect a merger, share exchange, or similar business combination, primarily targeting the medical technology and green energy sectors in North America, Europe, and Asia (excluding China, Hong Kong, and Macau).

As of November 2025, the company is in the final stages of a reverse merger transaction with Alps Life Sciences Inc. to create the combined entity, Alps Global Holding Pubco. The deadline to complete this business combination was extended to November 9, 2025, with an extension payment of $10,890.15 deposited into the trust account on October 4, 2025.

The company's market capitalization stands at approximately $10.55 million as of November 2025, with approximately 3.52 million shares outstanding.

The low number of public shares remaining-only 12,635 public shares were outstanding following the October 7, 2025, merger approval and subsequent redemptions-shows that most public investors took the cash-out option. This is defintely a high-risk, high-reward situation for the remaining shareholders.

Globalink Investment Inc.'s Ownership Breakdown

The ownership is concentrated among institutional investors and the original sponsor, GL Sponsor LLC, which holds the founder shares. Institutional ownership is substantial for the remaining float, giving these funds considerable sway in corporate governance matters.

Here's the quick math: with 3.52 million shares outstanding, institutional investors control roughly 982,880 shares (27.90% of 3.52M).

Globalink Investment Inc.'s Leadership

The current leadership team is composed of the executives and directors who have guided the company through its initial public offering (IPO) and the complex merger process with Alps Life Sciences Inc.

The team is responsible for corporate governance, compliance with SEC regulations, and the final execution of the business combination. You can find more details on their strategic direction in the Mission Statement, Vision, & Core Values of Globalink Investment Inc. (GLLI).

• Say Leong Lim: Chairman of the Board and Chief Executive Officer (CEO). Mr. Lim has led the company since its inception and is the primary driver of the merger strategy.
• Kelvin Chin: Chief Financial Officer (CFO) and Director. Mr. Chin manages the financial reporting and accounting duties, a critical function for a SPAC navigating a business combination.
• Hui Liang Wong: Independent Director. Ms. Wong provides independent oversight to the board, a key component of corporate governance.

This core team is tasked with ensuring the successful close of the merger and the transition to the new corporate structure of Alps Global Holding Pubco.

Globalink Investment Inc. (GLLI) Mission and Values

Globalink Investment Inc. (GLLI) stands for more than just a blank check; its core purpose is to deliver superior investment performance while upholding unwavering integrity and a client-centric approach, especially within the high-growth medical technology and green energy sectors. This focus on long-term, strategic value creation is the cultural defintely DNA that guides its SPAC (Special Purpose Acquisition Company) strategy.

Given Company's Core Purpose

As a SPAC, Globalink Investment Inc. operates with a mission that is less about current revenue generation-which was $0 for both Q1 and Q2 of the 2025 fiscal year-and more about the future value it aims to unlock through a strategic business combination. The company's core values are the principles that steer its search for the right merger target, like the one with ALPS Global Holding Berhad as of October 2025.

Official mission statement

The mission statement is clear: deliver superior investment performance and build lasting client relationships, all while being guided by integrity and a commitment to innovation. Honestly, for a company with a Q2 2025 net loss of -$893.9 K, this mission is a forward-looking promise, not a reflection of current operating results. Here's what that mission breaks down to:

• Deliver superior investment performance to clients.
• Build lasting relationships based on trust.
• Maintain unwavering integrity in all business practices.
• Foster a culture of continuous innovation.

Vision statement

The vision statement maps out GLLI's long-term aspiration, which is to be a globally recognized leader in investment management. It's about becoming renowned for expertise, innovation, and dedication to client success, which is a high bar for any firm, let alone one focused on complex mergers in the medical technology and green energy spaces. The vision is about global scale and reputation.

• Achieve global recognition as an investment leader.
• Be renowned for expertise and innovation.
• Demonstrate dedication to client success globally.

The core values-Integrity, Innovation, and a Client-Centric Approach-are the non-negotiables in the high-stakes world of SPAC mergers. You need trust when you're dealing with a blank check company, so these values are paramount. Mission Statement, Vision, & Core Values of Globalink Investment Inc. (GLLI).

Given Company slogan/tagline

The slogan is simple, but powerful, especially for a firm that is fundamentally a partnership vehicle.

• Investing in Your Future, Together.

This tagline emphasizes partnership and shared success with clients, highlighting the long-term focus required when investing in disruptive sectors like green energy. It's a clear message that their success is tied to yours. The collaborative approach is everything in a SPAC deal.

Globalink Investment Inc. (GLLI) How It Works

You need to understand that Globalink Investment Inc. (GLLI) is no longer a blank check company; it successfully completed its business combination with Alps Life Sciences Inc. on October 31, 2025. The combined entity is now operating as Alps Group Inc. (Nasdaq: ALPS) and functions as a fully integrated biotechnology platform.

The company's core mission is to deliver predictive, preventive, and precision medicine, moving beyond the traditional reactive healthcare model. It's a classic 'bench to bedside' strategy, meaning they control the process from initial research and development (R&D) all the way to delivering treatments and medical services to the patient.

Alps Group Inc.'s Product/Service Portfolio

The revenue stream for the combined entity is built on three pillars, which reflect the legacy Alps Life Sciences Inc. business. For the fiscal year ended March 31, 2025, the company reported revenue of about $3.4 million USD, mostly driven by the medical and aesthetic services side, which funds the heavy R&D investment.

Alps Group Inc.'s Operational Framework

The operational framework is centered on vertical integration-owning the entire value chain from discovery to delivery. This is defintely a high-cost model right now, with operating expenses hitting $39 million USD for the fiscal year ended March 31, 2025, leading to a net loss of about $2.4 million USD, but that's typical for a biotech company in a heavy investment phase.

The value creation process is structured around a few key operational hubs, mostly situated in Kuala Lumpur, Malaysia:

• Upstream R&D: Celestialab focuses on the cultivation and development of cellular products, including autologous stem cells.
• Diagnostic Core: MyGenome, a Bionexus accredited molecular laboratory, handles all the high-throughput genetic sequencing and mRNA analysis.
• Downstream Delivery: Alps Medical Centre and Alps Wellness Centre provide the direct patient interface, delivering medical services, precision treatments, and aesthetic solutions.
• Ecosystem Funding: Revenue generated from medical and aesthetic services is strategically used to fund the high-burn R&D pipeline-a smart way to manage the cash view.

You can dive deeper into the financial mechanics of this transition here: Breaking Down Globalink Investment Inc. (GLLI) Financial Health: Key Insights for Investors

Alps Group Inc.'s Strategic Advantages

The combined company's strategic advantage isn't just one thing; it's the deliberate creation of an integrated ecosystem that few competitors can match.

• Bench-to-Bedside Ecosystem: This fully integrated platform controls quality and cost across R&D, manufacturing (cGMP), and patient care, allowing for faster translation of research into commercial treatments.
• Geographic and Cost Arbitrage: The headquarters and core operational hubs are located in Kuala Lumpur, Malaysia, which allows for a lower or conservative burn rate on R&D and operational costs compared to major US or European biotech centers.
• Precision Medicine Focus: By integrating WGS (Whole Genome Sequencing) and cellular therapy, the company is positioned in the high-growth, high-value segment of personalized medicine.
• Strong Financial Backing/Valuation: The successful merger and subsequent Nasdaq listing, which valued the combined entity at an estimated enterprise value of approximately $1.6 billion USD, gives them a strong platform for future capital raises and partnerships.

Globalink Investment Inc. (GLLI) How It Makes Money

Globalink Investment Inc. (GLLI) operates as a Special Purpose Acquisition Company (SPAC), meaning its core business, prior to a merger, is not generating revenue from products or services. Instead, the company makes money primarily by earning non-operating interest income on the cash held in a trust account from its initial public offering (IPO).

The entire financial model hinges on successfully completing a business combination (De-SPAC) with a target company-in this case, Alps Global Holding Berhad-where the cash in the trust is used to fund the combined entity. As of the first half of the 2025 fiscal year, Globalink Investment's operating revenue was $0, as it had not yet commenced operations.

Globalink Investment Inc.'s Income Breakdown

To be clear, Globalink Investment Inc. has no traditional operating revenue; its financial inflows are entirely non-operating income. The table below reflects the breakdown of its total income for the six months ended June 30, 2025, which totaled $66,336.

Business Economics

The economics of a SPAC like Globalink Investment Inc. are unique and temporary. It's a shell company, essentially a pool of capital, not an operating business. The main economic driver is the spread between the interest earned on the trust account and the operating expenses required to find and execute a merger.

• Interest Income: The $3,726,817 in the trust account as of June 30, 2025, is invested, typically in short-term U.S. government securities. This interest income, which amounted to $66,336 in the first half of 2025, is primarily intended to cover income taxes.
• Sponsor Capital: The company relies heavily on its sponsor, GL Sponsor LLC, and related parties for working capital and extension fees. For instance, the company has issued promissory notes, totaling approximately $390,000 as of June 30, 2025, to fund the extension of the deadline to complete the merger. This is a liability, not revenue, but it's the lifeblood that keeps the SPAC alive.
• Pricing Strategy: The IPO shares were initially priced at $10.00 per unit, which sets the redemption value for public shareholders. This fixed price is the core economic promise to investors.

Here's the quick math: The total non-operating income of $66,336 is tiny compared to the total net loss of $1,632,451 in the same period, showing the sponsor is subsidizing the search. The real economic value is the potential for the common stock to trade higher than the $10.00 redemption price post-merger.

To be fair, the entire point of a SPAC is the merger, not the pre-deal income. You can find more detail on the strategic rationale in our Mission Statement, Vision, & Core Values of Globalink Investment Inc. (GLLI).

Globalink Investment Inc.'s Financial Performance

As of November 2025, Globalink Investment Inc.'s financial performance must be viewed through the lens of a pre-De-SPAC entity with significant liabilities and no operating revenue.

• Net Loss: For the six months ended June 30, 2025, the company reported a net loss of $1,632,451. This loss is driven by general and administrative expenses, interest expense, and tax penalties.
• Cash Position: Cash held in the Trust Account was $3,726,817 as of June 30, 2025. This is the primary asset protecting public shareholder value.
• Earnings Per Share (EPS): The diluted Earnings Per Share for the second quarter of 2025 was a loss of -$0.2439. This negative EPS is defintely typical for a non-operating SPAC.
• Liabilities: The company's Total Liabilities to Total Assets ratio was extremely high at 339.94% in a recent measurement period, a figure that highlights the precarious financial structure of a SPAC that has incurred significant debt (like promissory notes) and warrant liabilities without a corresponding operating asset base. This ratio is a major near-term risk.

The financial health of Globalink Investment Inc. is not measured by traditional profitability metrics, but by its ability to maintain sufficient cash in the trust and successfully close the merger with Alps Global Holding Berhad before the final deadline, which was recently extended to November 9, 2025.

Globalink Investment Inc. (GLLI) Market Position & Future Outlook

Globalink Investment Inc. (GLLI) is no longer a pure-play Special Purpose Acquisition Company (SPAC); its future is now anchored in the successful completion of its reverse merger with ALPS Global Holding Berhad, which was approved by stockholders in October 2025. This move pivots the company from a blank check entity with a market capitalization of approximately $40.45 million as of late October 2025, into an operating business focused on the high-growth medical technology and green energy sectors.

Competitive Landscape

You need to understand that GLLI's historical competition was in the crowded 'Blank Check' space, but its future competitive field is in MedTech and Green Energy. The table below reflects its position just prior to the merger's finalization, comparing it to peers in the SPAC industry, which is a better gauge of its organizational strength and capital base before the pivot. Honestly, market share in the SPAC world is less about sales and more about the size of the trust and the quality of the target acquisition.

Opportunities & Challenges

The real action is now in the post-merger opportunities, but you can't ignore the significant risks inherent in any de-SPAC transaction, especially in volatile sectors. The company's cash position was only about $22.17K in October 2025, plus the trust account, so working capital for the new operations is defintely crucial.

Industry Position

Globalink Investment Inc.'s current standing is defined by its transition. As a SPAC, it was an emerging small-cap investment in the 'Blank Checks' industry.

• Pre-Merger Standing: GLLI's position was precarious, evidenced by multiple extension deadlines, with the last extension pushing the completion date to November 9, 2025, requiring an extension payment of $10,890.15 into the trust account.
• Post-Merger Pivot: The company is now poised to compete in the medical technology and green energy sectors, aiming to disrupt its new markets. This shift is a complete change in industry and operational focus.
• Financial Context: With a Market Cap of around $40.45 million and a negative P/E ratio (due to no significant operations), the new entity starts as a small player in its chosen high-growth sectors, relying heavily on the acquired company's assets and business plan for future growth.

To understand the foundation of this new strategy, you should review the Mission Statement, Vision, & Core Values of Globalink Investment Inc. (GLLI). Finance: Track the final closing date of the merger and the subsequent financial statements of the combined entity to assess its true operational standing by year-end.